CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $234,384 | -21.9% | 4,175 | -8.9% | 0.16% | -33.9% |
Q3 2022 | $300,000 | +5.6% | 4,585 | -1.8% | 0.24% | +0.8% |
Q2 2022 | $284,000 | -68.0% | 4,667 | -60.2% | 0.24% | -72.7% |
Q1 2022 | $888,000 | 0.0% | 11,714 | 0.0% | 0.87% | 0.0% |
Q4 2021 | $888,000 | -43.2% | 11,714 | -16.1% | 0.87% | -40.9% |
Q3 2021 | $1,563,000 | -22.7% | 13,963 | +11.7% | 1.47% | -22.1% |
Q2 2021 | $2,023,000 | – | 12,498 | – | 1.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |